Avatrombopag Optimizes Response to Niraparib by Managing Thrombocytopenia Associated with Poly-ADP Ribose Polymerase (PARP) Inhibition in Ovarian Cancer and Breast Cancer: A Case Series

Case series Patients:— Final Diagnosis: Breast cancer • ovarian cancer Symptoms: Thrombocytopenia Medication: — Clinical Procedure: — Specialty: Oncology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Thrombocytopenia is a potentially treatment-limiting adverse event of particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabrail, Nash, Smith, Carrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682497/
https://www.ncbi.nlm.nih.gov/pubmed/33191394
http://dx.doi.org/10.12659/AJCR.927008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682497/
https://www.ncbi.nlm.nih.gov/pubmed/33191394
http://dx.doi.org/10.12659/AJCR.927008

Ejemplares similares